Henan Cancer Hostipal

Zhengzhou 450008

0 studies enrolling now · 4 studies all time

What they study most

ET (Essential Thrombocythemia), Locally Advanced Solid Tumors, Metastatic Nonsquamous Non-Small Cell Lung Cancer, Metastatic Solid Tumors, Metastatic Squamous Non-Small Cell Lung Cancer, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Neoplasm Overlap Syndrome, Myelofibrosis, Myeloproliferative Neoplasm, Post Essential Thrombocythemia Myelofibrosis, Post Polycythemia Vera Myelofibrosis, Primary Myelofibrosis

Studies at this site

• Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer — Completed
• Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms — Running, not enrolling
• To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304) — Stopped early
• A Phase 1 Study of INCMGA00012 in Patients With Advanced Solid Tumors — Completed